Activation of the AKT pathway promoting cell survival and proliferation was also observed by Leung et al. when studying the upregulation of Src-homology 2 domain–containing phosphatase 2 (SHP2) in resistant cell lines of HCC and patient derived tumor xenografts [97]. Here, PTPN11 is linked to hepatocellular carcinoma.